- Home
- ARMK vs TECH Comparison
ARMK vs TECH Comparison
Compare ARMK & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMK
- TECH
- Stock Information
- Founded
- ARMK 1959
- TECH 1976
- Country
- ARMK United States
- TECH United States
- Employees
- ARMK N/A
- TECH N/A
- Industry
- ARMK Restaurants
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ARMK Consumer Discretionary
- TECH Health Care
- Exchange
- ARMK Nasdaq
- TECH Nasdaq
- Market Cap
- ARMK 10.1B
- TECH 8.2B
- IPO Year
- ARMK 2013
- TECH 1989
- Fundamental
- Price
- ARMK $39.13
- TECH $61.84
- Analyst Decision
- ARMK Strong Buy
- TECH Buy
- Analyst Count
- ARMK 10
- TECH 12
- Target Price
- ARMK $45.20
- TECH $70.91
- AVG Volume (30 Days)
- ARMK 2.3M
- TECH 2.9M
- Earning Date
- ARMK 11-10-2025
- TECH 10-29-2025
- Dividend Yield
- ARMK 1.08%
- TECH 0.51%
- EPS Growth
- ARMK 3.13
- TECH N/A
- EPS
- ARMK 1.36
- TECH 0.46
- Revenue
- ARMK $17,874,782,000.00
- TECH $1,219,635,000.00
- Revenue This Year
- ARMK $9.18
- TECH $3.97
- Revenue Next Year
- ARMK $5.66
- TECH $7.81
- P/E Ratio
- ARMK $28.72
- TECH $136.85
- Revenue Growth
- ARMK 4.02
- TECH 5.23
- 52 Week Low
- ARMK $29.92
- TECH $46.01
- 52 Week High
- ARMK $44.49
- TECH $80.80
- Technical
- Relative Strength Index (RSI)
- ARMK 57.18
- TECH 69.59
- Support Level
- ARMK $37.72
- TECH $50.13
- Resistance Level
- ARMK $39.35
- TECH $63.87
- Average True Range (ATR)
- ARMK 0.70
- TECH 2.26
- MACD
- ARMK 0.23
- TECH 1.27
- Stochastic Oscillator
- ARMK 91.26
- TECH 85.59
About ARMK Aramark
Aramark, founded in 1936 and headquartered in Philadelphia, Pennsylvania, operates as a food service company providing facility management and workplace solutions. The company primarily generates revenue from its North American food and support services segment, serving various clients including schools, healthcare facilities, and entertainment venues.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.